Hamish Ogston Foundation commits to supporting snakebite research
As part of our philanthropic objective to help resolve underrepresented global health issues, the Hamish Ogston Foundation has committed to supporting essential research into effective treatments for snakebite victims. Snakebites are a neglected tropical disease that affects hundreds of thousands around the world, causing enormous suffering and hardship in impoverished areas.
Caption: Villagers in Myanmar, Burma, one of the areas worst affected by snakebites.
Here’s Hamish Ogston’s statement on the news.
I am pleased to announce that the Hamish Ogston Foundation has committed to supporting snakebite research in three of the Asian countries worst affected by this neglected tropical disease.
The Hamish Ogston Foundation has pledged substantial funding, in the region of £3.4 million, to these programmes which will be carried out over three years in Myanmar, Vietnam and India.
In 2019, studies will begin on the effectiveness and safety of currently available and recently developed antidotes to snake venoms, known as antivenoms. The results of this research will give doctors objective evidence and reliable guidelines for using these essential drugs.
In addition, trials will begin using revolutionary ancillary drugs that block the action of lethal venom enzyme toxins. These novel remedies will be used alongside antivenoms in treating bites by the notorious Russell’s viper in Myanmar and against the serious local tissue damage caused by spitting cobra bites in Vietnam, for which conventional antivenoms have proved ineffective.
The results achieved by the programme will be passed on to the national ministries of health and international organisations such as WHO for widespread implementation.
To find out more about the global snakebite crisis, read our blog article ‘The global snakebite crisis: How the Hamish Ogston Foundation is shining a light on a neglected disease’.